Curriculum
Mind Over Memory: Early Identification and New Treatment Options for Alzheimer Disease
CME Information
1.75 AMA PRA Category 1 Credits, 1.75 ABIM MOC or 1.72 AANP, 0.78 AANP Pharm
Release Date: 1/24/2024
Available for credit until 1/24/2025
Learning Objectives
- Discuss the evaluation involved in diagnosing AD or MCI due to AD, including the expanding role of biomarkers to aid early and accurate diagnosis
- Examine the roles of PCPs and dementia specialists in the diagnosis and management of AD
- Explore the evidence supporting new and emerging anti-amyloid therapies
- Consider which patients are most likely to benefit from these therapies
- Answer frequently asked questions regarding advances in treatment for Alzheimer disease
Courses
1.75 CME/CE CREDITS
4 Courses
-
Podcast
-
Podcast
-
Podcast
-
Podcast
Supporters and Partners
Supported by
Eisai Inc.
Education Partner
Pri-Med Institute